GleanMark

PRIMEBODY Trademark

PRIMEBODY is a USPTO trademark filed by Voro Therapeutics, Inc.. Status: Pending.

Trademark Facts

MarkPRIMEBODY
Serial Number99503974
StatusPending
Filing Date2025-11-19
Mark TypeWord
Nice Classes005 (Pharmaceuticals), 042 (Software & IT)
OwnerVoro Therapeutics, Inc.
Attorney of RecordGayani R Weerasinghe
Prosecution Events7
Latest EventGNRT on 2026-04-15

Goods & Services

Class 005: Pharmaceutical preparations for the treatment of cancer, immune-related, autoimmune, metabolic, and inflammatory diseases; therapeutic pharmaceuticals for the treatment of cancer, immune-related, autoimmune, metabolic, and inflammatory diseases; pharmaceutical preparations, namely, pro drug or drug delivery systems comprising biologics for conditional activation, tissue or tumor targeting; therapeutic and diagnostic agents, preparations, and substances for medical purposes; pharmaceutical preparations and substances for use in the field of oncology, immunology, autoimmune, metabolic, and inflammatory diseases; therapeutic and diagnostic agents and preparations consisting primarily of biochemicals for medical use; Class 042: Scientific and technological research and development in the fields of pharmaceuticals, biotechnology, and medical diagnostics namely, preparations, biologics, and diagnostic agents; development of drugs for oncology, immunology, autoimmune, metabolic, and inflammatory diseases, conditionally-activated or tumor-activated therapeutics or biologics; providing a scientific and technological platform for research and development of drug candidates; conducting clinical and pre-clinical research in the field of pharmaceuticals and biotechnology; pharmaceutical research, development, and analysis, namely relating to the treatment of cancer, immune-related, autoimmune, metabolic, and inflammatory diseases; providing scientific information and data relating to pharmaceutical, biotechnological, and clinical research

Recent Prosecution Activity

DateDocumentType
2026-04-15Notice of Non-Final Office ActionNFO
2026-04-15Non-Final ActionNFIN

USPTO Refusals on Record

Related